株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価

Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 404488
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価 Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月01日 ページ情報: 英文 128 Pages
概要

当レポートでは、世界の電気生理学 (EP) アブレーションカテーテルの市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 前立腺がん診断検査の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 EPアブレーションカテーテル:各企業で現在治験中のパイプライン製品

  • EPアブレーションカテーテルの企業:治験段階別のパイプライン製品
  • EPアブレーションカテーテル:治験段階別のパイプライン製品

第5章 EPアブレーションカテーテルの企業・製品の概要

  • Advanced Cardiac Therapeutics, Inc.
    • パイプライン製品および進行中の治験の概要
  • Apama Medical, Inc.
  • Biosense Webster Inc
  • BioTex Inc
  • Boston Scientific Corp
  • Cardima, Inc. (Inactive)
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corp
  • CryoTherapeutics Gmbh
  • Epicardial Technologies Inc
  • FocusStart LLC
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic US
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific Corporation
  • North Carolina State University
  • Northwestern University
  • Ra Medical Systems Inc
  • SCR, Inc.
  • St. Jude Medical Inc
  • Stereotaxis Inc
  • Strategic Polymer Sciences, Inc
  • University of Iowa
  • University of Michigan
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vanderbilt University
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical (Inactive)

第6章 EPアブレーションカテーテル市場:昨今の動向 (全47件)

第7章 提言

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0466EPD

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2017" provides an overview of Electrophysiology Ablation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Ablation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Ablation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Electrophysiology Ablation Catheters Overview 9

3 Products under Development 10

  • 3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • 3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • 3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • 3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • 3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • 3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies 16

  • 4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
  • 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18

5 Electrophysiology Ablation Catheters Companies and Product Overview 20

  • 5.1 Ablacon Inc Company Overview 20
    • 5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 21
    • 5.2.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Apama Medical, Inc. Company Overview 22
    • 5.3.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Biosense Webster Inc Company Overview 23
    • 5.4.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 BioTex Inc Company Overview 27
    • 5.5.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.6 Boston Scientific Corp Company Overview 29
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Cardima, Inc. (Inactive) Company Overview 36
    • 5.7.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.8 CardioFocus Inc Company Overview 38
    • 5.8.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.9 CardioNova Ltd Company Overview 39
    • 5.9.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.10 CathEffects LLC Company Overview 40
    • 5.10.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.11 CathRx Ltd Company Overview 41
    • 5.11.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.12 Columbia University Company Overview 44
    • 5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.13 Cordis Corp Company Overview 45
    • 5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.14 CryoTherapeutics Gmbh Company Overview 46
    • 5.14.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.15 Epicardial Technologies Inc Company Overview 47
    • 5.15.1 Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.16 FocusStart LLC Company Overview 48
    • 5.16.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.17 Interventional Imaging, Inc. Company Overview 49
    • 5.17.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.18 Iowa Approach Inc. Company Overview 50
    • 5.18.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.19 Maestro Heart SA Company Overview 53
    • 5.19.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.20 Mayo Clinic US Company Overview 54
    • 5.20.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.21 Medlumics SL Company Overview 55
    • 5.21.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.22 Medtronic plc Company Overview 56
    • 5.22.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.23 MedWaves Inc Company Overview 60
    • 5.23.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.24 MicroPort Scientific Corp Company Overview 61
    • 5.24.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.25 North Carolina State University Company Overview 63
    • 5.25.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.26 Northwestern University Company Overview 64
    • 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.27 SCR, Inc. Company Overview 65
    • 5.27.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.28 St. Jude Medical LLC Company Overview 66
    • 5.28.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.29 Stereotaxis Inc Company Overview 68
    • 5.29.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.30 Strategic Polymer Sciences, Inc Company Overview 69
    • 5.30.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.31 University of Michigan Company Overview 70
    • 5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.32 University of Rochester Company Overview 71
    • 5.32.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.33 University of Texas Medical Branch at Galveston Company Overview 72
    • 5.33.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.34 Vanderbilt University Company Overview 73
    • 5.34.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.35 Vimecon GmbH Company Overview 74
    • 5.35.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.36 Vivonics, Inc. Company Overview 75
    • 5.36.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.37 Voyage Medical (Inactive) Company Overview 76
    • 5.37.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76

6 Electrophysiology Ablation Catheters- Recent Developments 77

  • 6.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 77
  • 6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 78
  • 6.3 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 81
  • 6.4 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
  • 6.5 Aug 01, 2017: FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization 82
  • 6.6 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 83
  • 6.7 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 85
  • 6.8 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 86
  • 6.9 Jul 11, 2017: Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation 86
  • 6.10 Jul 07, 2017: MPSC New COO Glendy Wang on Board 87
  • 6.11 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 87
  • 6.12 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 89
  • 6.13 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 90
  • 6.14 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic 3D Irrigated Ablation Catheter 93
  • 6.15 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic Cardiac RF Ablation Catheter 93
  • 6.16 May 09, 2017: Abbott Announces CE Mark for TactiCath Contact Force Ablation Catheter, Sensor Enabled 93
  • 6.17 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 95
  • 6.18 Apr 27, 2017: Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool RF Ablation System 96
  • 6.19 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 96
  • 6.20 Apr 23, 2017: Bard Announces First Quarter Results 97
  • 6.21 Mar 30, 2017: Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation 98
  • 6.22 Mar 30, 2017: MPSC Announces 2016 Annual Results 99
  • 6.23 Mar 21, 2017: Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Texas and Among First in U.S. to Use FlexAbility Ablation Catheter, Sensor Enabled 100
  • 6.24 Mar 10, 2017: FireMagic Cardiac RF Ablation Catheter Gains MFDS Approval 101
  • 6.25 Mar 01, 2017: Abbott Announces FDA Approval Of Flexability Ablation Catheter, Sensor Enabled To Advance The Treatment Of Complex Cardiac Arrhythmias 102
  • 6.26 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 102
  • 6.27 Feb 16, 2017: FDA Approves Expanded Indication for Medtronic Freezor Xtra Cryoablation Catheter 105
  • 6.28 Feb 15, 2017: Medtronic's OsteoCool RF Ablation System Receives Expanded Indication for Palliative Treatment of Metastatic Bone Tumors 106
  • 6.29 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 107
  • 6.30 Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 107
  • 6.31 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 109
  • 6.32 Jan 26, 2017: Bard Announces Fourth Quarter Results 110
  • 6.33 Jan 19, 2017: CardioFocus Announces Initial Clinical Evaluation of Next-Generation HeartLight Excalibur Balloon Designed For the Treatment of Atrial Fibrillation 111
  • 6.34 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 112
  • 6.35 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 115
  • 6.36 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 115
  • 6.37 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 116
  • 6.38 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 118
  • 6.39 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 118
  • 6.40 Oct 25, 2016: Bard Announces Third Quarter Results 120
  • 6.41 Oct 19, 2016: FireMagic Cool Catheter Obtains CFDA Approval 120
  • 6.42 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 121
  • 6.43 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 123
  • 6.44 Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 123

7 Appendix 125

  • 7.1 Methodology 125
  • 7.2 About GlobalData 128
  • 7.3 Contact Us 128
  • 7.4 Disclaimer 128

List of Tables

1.1 List of Tables

  • Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
  • Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
  • Table 8: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
  • Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 10: Ablasense - Product Status 20
  • Table 11: Ablasense - Product Description 20
  • Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 13: ACT Cardiac Ablation Catheter - Product Status 21
  • Table 14: ACT Cardiac Ablation Catheter - Product Description 21
  • Table 15: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 16: Apama Ablation Catheter - Product Status 22
  • Table 17: Apama Ablation Catheter - Product Description 22
  • Table 18: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 19: CARTO SMARTTOUCH 5D Catheter - Product Status 23
  • Table 20: CARTO SMARTTOUCH 5D Catheter - Product Description 23
  • Table 21: Next Generation Ablation Catheter - Product Status 24
  • Table 22: Next Generation Ablation Catheter - Product Description 24
  • Table 23: Biosense Webster Inc - Ongoing Clinical Trials Overview 25
  • Table 24: CARTO SMARTTOUCH 5D Catheter - Clinical Study for Workflow and Acute Performance Evaluation of the Thermocool Smarttouch SF-5D System (The Thermocool Smarttouch SF-5D Catheter with Temperature Sensing Capabilities and Micro Electrodes and CARTO 3 V 6.0 Technology) in Treatment of Patie 26
  • Table 25: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 26: Cooled Tip Catheter - Product Status 27
  • Table 27: Cooled Tip Catheter - Product Description 27
  • Table 28: Water-cooled Catheter - Product Status 28
  • Table 29: Water-cooled Catheter - Product Description 28
  • Table 30: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 31: Cryo Balloon Catheter - Product Status 29
  • Table 32: Cryo Balloon Catheter - Product Description 29
  • Table 33: DirectSense Rx Catheter - Product Status 30
  • Table 34: DirectSense Rx Catheter - Product Description 30
  • Table 35: Force Sensing Afib Catheter - Product Status 30
  • Table 36: Force Sensing Afib Catheter - Product Description 30
  • Table 37: IntellaNav MiFi OI AF Ablation Catheter - Product Status 31
  • Table 38: IntellaNav MiFi OI AF Ablation Catheter - Product Description 31
  • Table 39: Next Generation Blazer Catheter - Product Status 31
  • Table 40: Next Generation Blazer Catheter - Product Description 32
  • Table 41: Next Generation IntellaTip Catheter - Product Status 32
  • Table 42: Next Generation IntellaTip Catheter - Product Description 32
  • Table 43: Boston Scientific Corp - Ongoing Clinical Trials Overview 33
  • Table 44: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 34
  • Table 45: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study 35
  • Table 46: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 47: CADENCE EPL - Product Status 36
  • Table 48: CADENCE EPL - Product Description 36
  • Table 49: EP Ablation System - Product Status 37
  • Table 50: EP Ablation System - Product Description 37
  • Table 51: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 52: HeartLight Excalibur Balloon - Product Status 38
  • Table 53: HeartLight Excalibur Balloon - Product Description 38
  • Table 54: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 55: Catheter To Treat Atrial Fibrillation - Product Status 39
  • Table 56: Catheter To Treat Atrial Fibrillation - Product Description 39
  • Table 57: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 58: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 40
  • Table 59: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 40
  • Table 60: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 61: CathRx 4mm Therapeutic Catheter - Product Status 41
  • Table 62: CathRx 4mm Therapeutic Catheter - Product Description 41
  • Table 63: CathRx 8mm Therapeutic Catheter - Product Status 42
  • Table 64: CathRx 8mm Therapeutic Catheter - Product Description 42
  • Table 65: Khelix Irrigated Ablation EP Catheter - Product Status 42
  • Table 66: Khelix Irrigated Ablation EP Catheter - Product Description 43
  • Table 67: Khelix Non-Irrigated Ablation EP Catheter - Product Status 43
  • Table 68: Khelix Non-Irrigated Ablation EP Catheter - Product Description 43
  • Table 69: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 70: Optically-Integrated RFA Catheter - Product Status 44
  • Table 71: Optically-Integrated RFA Catheter - Product Description 44
  • Table 72: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 73: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 45
  • Table 74: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 45
  • Table 75: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 76: Cryotherapy System - Coronary Artery Disease - Product Status 46
  • Table 77: Cryotherapy System - Coronary Artery Disease - Product Description 46
  • Table 78: Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 79: Epicardial Access Device - Product Status 47
  • Table 80: Epicardial Access Device - Product Description 47
  • Table 81: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 82: Anti-coagulum Cardiac Ablation Catheter - Product Status 48
  • Table 83: Anti-coagulum Cardiac Ablation Catheter - Product Description 48
  • Table 84: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 85: Atrial Fibrillation Catheter - Product Status 49
  • Table 86: Atrial Fibrillation Catheter - Product Description 49
  • Table 87: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 88: MaPP-CS - Product Status 50
  • Table 89: MaPP-CS - Product Description 50
  • Table 90: ROF-AC - Product Status 51
  • Table 91: ROF-AC - Product Description 51
  • Table 92: ROF-AS - Product Status 51
  • Table 93: ROF-AS - Product Description 52
  • Table 94: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 95: Maestro-AF Catheter System - Product Status 53
  • Table 96: Maestro-AF Catheter System - Product Description 53
  • Table 97: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 98: Pulmonary Vein Ablation Device - Product Status 54
  • Table 99: Pulmonary Vein Ablation Device - Product Description 54
  • Table 100: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 101: RF Ablation Catheter - Product Status 55
  • Table 102: RF Ablation Catheter - Product Description 55
  • Table 103: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 104: PVAC Gold - Product Status 56
  • Table 105: PVAC Gold - Product Description 57
  • Table 106: Medtronic plc - Ongoing Clinical Trials Overview 58
  • Table 107: PVAC Gold - Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry) 59
  • Table 108: PVAC Gold - PVAC GOLD Versus Irrigated RF Single Tip Catheter with Contact Force Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation 59
  • Table 109: PVAC Gold - The Prospective, Multicenter Canadian Atrial Fibrillation PVAC Cohort Study 59
  • Table 110: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 111: Arrhythmia Catheters - Product Status 60
  • Table 112: Arrhythmia Catheters - Product Description 60
  • Table 113: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 114: Circular Ablation Catheter - Product Status 61
  • Table 115: Circular Ablation Catheter - Product Description 61
  • Table 116: Voyager Irrigated RF Ablation Catheter - Product Status 62
  • Table 117: Voyager Irrigated RF Ablation Catheter - Product Description 62
  • Table 118: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 119: Robotic Catheter - Product Status 63
  • Table 120: Robotic Catheter - Product Description 63
  • Table 121: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 122: Cardiac Catheter - Product Status 64
  • Table 123: Cardiac Catheter - Product Description 64
  • Table 124: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 125: Atrial Fibrillation Device - Product Status 65
  • Table 126: Atrial Fibrillation Device - Product Description 65
  • Table 127: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 128: All-in-one Catheter Ablation System - Product Status 66
  • Table 129: All-in-one Catheter Ablation System - Product Description 66
  • Table 130: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Status 67
  • Table 131: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Description 67
  • Table 132: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 133: Next Generation Irrigated Magnetic Catheter - Product Status 68
  • Table 134: Next Generation Irrigated Magnetic Catheter - Product Description 68
  • Table 135: Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 136: Electroactive Polymer Based Steerable Catheter - Product Status 69
  • Table 137: Electroactive Polymer Based Steerable Catheter - Product Description 69
  • Table 138: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 139: Non-Contact Mapping Catheter - Product Status 70
  • Table 140: Non-Contact Mapping Catheter - Product Description 70
  • Table 141: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 142: RF Ablation Catheter - Product Status 71
  • Table 143: RF Ablation Catheter - Product Description 71
  • Table 144: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 145: Ablation Catheter - Product Status 72
  • Table 146: Ablation Catheter - Product Description 72
  • Table 147: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 148: Temperature Controlled Catheter - Product Status 73
  • Table 149: Temperature Controlled Catheter - Product Description 73
  • Table 150: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 151: Vimecon Catheter - Product Status 74
  • Table 152: Vimecon Catheter - Product Description 74
  • Table 153: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 154: Catheter Guidance System - Product Status 75
  • Table 155: Catheter Guidance System - Product Description 75
  • Table 156: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 157: IRIS Ablation System - Product Status 76
  • Table 158: IRIS Ablation System - Product Description 76
  • Table 159: Glossary 127

List of Figures

1.2 List of Figures

  • Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
Back to Top